Lifemd Inc (LFMD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lifemd Inc   (NASDAQ: LFMD)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Lifemd Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lifemd Inc's ROI in the second quarter of 2026?
Lifemd Inc achieved a return on average invested assets (ROI) of 2.32 % in its second quarter of 2026, this is above LFMD's average return on investment of -3838.75%.
Lifemd Inc invested over the 12 months ending in its second quarter of 2026 $19 million

ROI fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

Within the Healthcare sector 163 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 112 to 146.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 70.14 % 35.95 % -5.51 % -48.42 % -36.45 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 13 21 29 11 8
Return On Investment (TTM) 2.32 % 34.8 % 105.75 % -50.54 % -55.03 %
LFMD's Overall Ranking # 146 # 112 # 28 # 3160 # 3125
Seq. Investment Change TTM 8.36 % 19.12 % 48.38 % -11.16 % -13.42 %
Seq. Net Income Change TTM -92.77 % -60.8 % - - -
Net Income (TTM) in Millions 0 6 15 -5 -6

LFMD Company Profile >> Back to LFMD Roi Comparisons >> See Annual LFMD Return On Investment



Return On Investment LFMD's Ranking
Within: No.
Industry # 21
Sector # 164
Overall # 146

Return On Investment Statistics
High Average Low
335.03 %
-3838.75 %
-66829.21 %
(Mar 31 2018)   (Jun 30 2021)



  News about Lifemd Inc Return on Investment ROI

LifeMD Expands Insurance Acceptance for Medicare Beneficiaries Amid Ongoing Stock Struggles,

April 17, 2025

LifeMD Expands Reach to Medicare Beneficiaries, But Shares Trail Market Performance LifeMD Inc. (NASDAQ: LFMD) is poised to make a significant impact in the virtual healthcare landscape by expanding its insurance acceptance to Medicare beneficiaries. The company announced that its virtual primary care services, including its weight loss programs, are now accessible to over 21 million individuals enrolled in Medicare Part B across 26 states. Furthermore, LifeMD plans to extend these qualifying services to nearly all states, aiming for a total of 49 states by the end of the second quarter of this year. This strategic move positions LifeMD to capitalize on the growing demand for telehealth services, especially among older adults who increasingly seek convenient and accessible healthcare options. With Medicare beneficiaries representing a significant portion of the U.S. population, this expansion could dramatically increase the company’s customer base and revenue potential. Despite this promising development, LifeMD s stock performance has been disappointing. As of the writing of this article, LifeMD Inc. s shares stand at $5.16, reflecting a troubling 47.98% decline over the past year. In comparison, the overall market has achieved a modest gain of 6.83% during the same timeframe. Notably, this month has witnessed LifeMD shares trailing the performance of the broader market, indicating investor concerns over the company’s financial health and growth strategy.Additionally, in the past week, LifeMD s stock has performed worse than the average performance of its customers, whose shares have declined by just 2.39%. This disparity raises questions about the company s ability to attract and retain investor confidence despite its expansion efforts.





Financial Statements
Lifemd Inc's II. Quarter Investments $ 13 Millions LFMD's Balance sheet
Lifemd Inc's II. Quarter Income $ -7 Millions Quarterly LFMD's Income Statement
LFMD's Income by Division See LFMD's Income by Division


LFMD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 29 14 26 -11 26
Y / Y Investment Growth 111.34 % -47.03 % - - -
Net Income in Millions 16 -19 -18 -45 -61
Y / Y Net Income Growth - - - - -
Annual Return On Investment 54.16 % -137.25 % -69.25 % - -235.27 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 54.16 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LFMD's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LFMD's Competitors
Subscribers only: Roi for Lifemd Inc's Suppliers
Subscribers only: Return On Investment for LFMD's Customers

Other Ratios
LFMD's Roa LFMD's Inventory Turnover Ratio LFMD's Growth Rates LFMD's Dividend Statistics
LFMD's Profitability Ratios LFMD's Asset Turnover Ratio LFMD's Dividend Growth
LFMD's Roe LFMD's Valuation Ratios LFMD's Financial Strength Ratios LFMD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Labcorp Holdings Inc   6.11 %
Royalty Pharma Plc  6.09 %
Pacs Group Inc   5.86 %
Merit Medical Systems Inc  5.80 %
Ensign Group Inc  5.75 %
Nrc Health  5.72 %
IMPACT BIOMEDICAL INC.  5.68 %
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %

Date modified: 2026-09-09T00:02:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.